scholarly journals CMS: An adapter molecule involved in cytoskeletal rearrangements

1999 ◽  
Vol 96 (11) ◽  
pp. 6211-6216 ◽  
Author(s):  
K. H. Kirsch ◽  
M.-M. Georgescu ◽  
S. Ishimaru ◽  
H. Hanafusa
2021 ◽  
Vol 22 (13) ◽  
pp. 6839
Author(s):  
Ali H. El-Far ◽  
Yaser H. A. Elewa ◽  
Elsayeda-Zeinab A. Abdelfattah ◽  
Abdel-Wahab A. Alsenosy ◽  
Mustafa S. Atta ◽  
...  

D-galactose (D-gal) administration causes oxidative disorder and is widely utilized in aging animal models. Therefore, we subcutaneously injected D-gal at 200 mg/kg BW dose to assess the potential preventive effect of thymoquinone (TQ) and curcumin (Cur) against the oxidative alterations induced by D-gal. Other than the control, vehicle, and D-gal groups, the TQ and Cur treated groups were orally supplemented at 20 mg/kg BW of each alone or combined. TQ and Cur effectively suppressed the oxidative alterations induced by D-gal in brain and heart tissues. The TQ and Cur combination significantly decreased the elevated necrosis in the brain and heart by D-gal. It significantly reduced brain caspase 3, calbindin, and calcium-binding adapter molecule 1 (IBA1), heart caspase 3, and BCL2. Expression of mRNA of the brain and heart TP53, p21, Bax, and CASP-3 were significantly downregulated in the TQ and Cur combination group along with upregulation of BCL2 in comparison with the D-gal group. Data suggested that the TQ and Cur combination is a promising approach in aging prevention.


2010 ◽  
Vol 9 (1) ◽  
pp. 9 ◽  
Author(s):  
Silvia Gluderer ◽  
Erich Brunner ◽  
Markus Germann ◽  
Virginija Jovaisaite ◽  
Changqing Li ◽  
...  
Keyword(s):  

2006 ◽  
Vol 80 (6) ◽  
pp. 1480-1490 ◽  
Author(s):  
Elena B. Lasunskaia ◽  
Mariana N. N. Campos ◽  
Marcelle R. M. de Andrade ◽  
Renato A. DaMatta ◽  
Thereza L. Kipnis ◽  
...  

Author(s):  
João Gonçalves ◽  
Helena Soares ◽  
Norman L. Eberhardt ◽  
Sarah C. R. Lummis ◽  
David R. Soto-Pantoja ◽  
...  
Keyword(s):  

2018 ◽  
Author(s):  
Ylenia Perone ◽  
Aaron J. Farrugia ◽  
Alba Rodriguez Meira ◽  
Balázs Győrffy ◽  
Charlotte Ion ◽  
...  

AbstractApproximately 30% of women diagnosed with ERα breast cancer relapse with metastatic disease following adjuvant treatment with endocrine therapies1,2. The connection between acquisition of drug resistance and invasive potential is poorly understood. In this study, we demonstrate that the type II keratin topological associating domain (TAD)3 undergoes epigenetic reprogramming in cells that develop resistance to aromatase inhibitors (AI), leading to keratin 80 (KRT80) upregulation. In agreement, an increased number of KRT80-positive cells are observed at relapse in vivo while KRT80 expression associates with poor outcome using several clinical endpoints. KRT80 expression is driven by de novo enhancer activation by sterol regulatory element-binding protein 14 (SREBP1). KRT80 upregulation directly promotes cytoskeletal rearrangements at the leading edge, increased focal adhesion maturation and cellular stiffening, which collectively promote cancer cell invasion. Shear-wave elasticity imaging of prospective patients shows that KRT80 levels correlate with stiffer tumors in vivo. Collectively, our data uncover an unpredicted and potentially targetable direct link between epigenetic and cytoskeletal reprogramming promoting cell invasion in response to chronic AI treatment.


1995 ◽  
Vol 752 (1 Cardiac Growt) ◽  
pp. 128-130 ◽  
Author(s):  
HANS M. EPPENBERGER ◽  
MONIKA EPPENBERGER-EBERHARDT ◽  
CECILIA HERTIG

Sign in / Sign up

Export Citation Format

Share Document